Seite - (000407) - in Biomedical Chemistry: Current Trends and Developments

Nembrini, C., Stano, A., Dane, K. Y., et al. (2011). Nanoparticle conjugation of antigen enhances cytotoxic t-cell responses in pulmonary vaccination. Proceedings of the National Academy of Sciences, 108(44), E989-997. Nicolas, J., Mura, S., Brambilla, D., et al. (2013). Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chemical Society Reviews, 42(3), 1147-1235. Offringa, R. (2009). Antigen choice in adoptive t-cell therapy of cancer. Current Opinion in Immunology, 21(2), 190-199. Oki, Y., Younes, A. (2012). Brentuximab vedotin in systemic t-cell lymphoma. Expert Opinion on Biological Therapy, 12(5), 623-632. Otsuka, H., Nagasaki, Y., Kataoka, K. (2003). Pegylated nanoparticles for biological and pharmaceutical applications. Advanced Drug Delivery Reviews, 55(3), 403-419. Owen, S. C., Doak, A. K., Wassam, P., et al. (2012). Colloidal aggregation affects the efficacy of anticancer drugs in cell culture. ACS Chemical Biology, 7(8), 1429-1435. Oyewumi, M. O., Kumar, A., Cui, Z. (2010). Nano-microparticles as immune adjuvants: Correlating particle sizes and the resultant immune responses. Expert Reviews of Vaccines, 9(9), 1095-1107. Padera, T. P., Stoll, B. R., Tooredman, J. B., et al. (2004). Pathology: Cancer cells compress intratumour vessels. Nature, 427(6976), 695. Pan, D., Caruthers, S. D., Chen, J., et al. (2010). Nanomedicine strategies for molecular targets with mri and optical imaging. Future Medicinal Chemistry, 2(3), 471-490. Park, J. H., Cho, H. J., Yoon, H. Y., et al. (2014). Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. Journal of Controlled Release, 174, 98-108. Park, J. H., Gu, L., von Maltzahn, G., et al. (2009). Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature Materials, 8(4), 331-336. Park, Y. M., Lee, S. J., Kim, Y. S., et al. (2013). Nanoparticle-based vaccine delivery for cancer immunotherapy. Immune Network, 13(5), 177-183. Paulo, C. S., Pires das Neves, R., Ferreira, L. S. (2011). Nanoparticles for intracellular-targeted drug delivery. Nanotechnology, 22(49), 494002. Pawelec, G., Rees, R. C., Kiessling, R., et al. (1999). Cells and cytokines in immunotherapy and gene therapy of cancer. Critical Reviews in Oncogenesis, 10(1-2), 83-127. Peer, D., Karp, J. M., Hong, S., et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751-760. Perche, F., Benvegnu, T., Berchel, M., et al. (2011). Enhancement of dendritic cells transfection in vivo and of vaccination against b16f10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA. Nanomedicine, 7(4), 445-453. Perez-Medina, C., Abdel-Atti, D., Zhang, Y., et al. (2014). A modular labeling strategy for in vivo pet and near-infrared fluorescence imaging of nanoparticle tumor targeting. Journal of Nuclear Medicine, 55(10), 1706-1711. Perrault, S. D., Walkey, C., Jennings, T., et al. (2009). Mediating tumor targeting efficiency of nanoparticles through design. Nano Letters, 9(5), 1909-1915. Peters, P. J., Borst, J., Oorschot, V., et al. (1991). Cytotoxic t lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. Journal of Experimental Medicine,